Select Page

Researchers Develop Method for Identifying Radiation-Resistant Tumors

by | Jul 2, 2018 | Research News |

New research at the University of Arkansas has found a way to identify radiation-resistant cancer cells, a breakthrough in the treatment of lung cancer that uses imaging to evaluate the response to treatment and match treatment to specific tumor cells.

Until now, there has been no way to determine immediately after beginning therapy if a tumor is resistant to radiation therapy or not. The findings were published this month in Scientific Reports, a Nature journal.

Narasimhan Rajaram

“Our results demonstrate that the use of autofluorescence imaging of cell metabolism can identify treatment-resistant cancer cells,” said Narasimhan Rajaram, assistant professor of biomedical engineering at the University of Arkansas and lead researcher on the project. “More importantly, we think that this technique provides a sound method to evaluate tumor response to treatment and match tumors to the right therapy.”

Using an innovative imaging system, a team of researchers from the University of Arkansas and the University of Arkansas for Medical Sciences has identifed differences between the metabolic response of radiation-resistant and radiation-sensitive lung cancer cells following therapy.

The researchers used autofluorescence imaging to observe changes in two molecules – nicotinamide adenine dinucleotide (NADH), and flavin adenine dinucleotide (FAD) – that both naturally absorb and emit light. These molecules  play a critical role in the major metabolic pathways within cells that are responsible for respiration and energy production. By measuring the relative contributions of NADH and FAD to these processes, researchers can evaluate biochemical details related to cell metabolism.

Previous research by this team compared radiation-resistant cancer cells to raditation-sensitive cells and found that radiation-resistant cells have higher levels of  hypoxia-inducible factor, which regulates the amount of oxygen in the cellular environment and protects the cancer cells from the damaging effects of radiation. In the most recent study, the researchers used autoflourescence imaging to observe changes in cell metabolism after exposure to radiation and the chemotherapy drug YC-1. YC-1 has shown promise improving the effectiveness of radiotherapy on radiation-resistant cancer cells by inhibiting hypoxia-inducible factor.

The researchers observed significant metabolic differences between radiation-resistant and radiation-responsive cells following exposure to radiation only and exposure to YC-1 only. However, all differences between the resistant and responsive cells were eliminated when the researchers combined radiation and chemotherapy. These results suggest that YC-1 made radiation-resistant cells more sensitive to radiation treatment, and that this effect could be observed using autoflourescence imaging.

The large interdisciplary team led by Rajaram, includes Kyle Quinn, assistant professor of biomedical engineering; Kinan Alhallak, graduate student in biomedical engineering; Nicholas Greene, assistant professor of exercise science; David Lee, doctoral student in kinesiology; and Ruud Dings and Robert Griffin, faculty in the Department of Radiation Oncology at the University of Arkansas for Medical Sciences.

Funding for this work was provided by the Arkansas Biosciences Insititute, the National Institutes of Health and the National Institute of General Medical Sciences.

About The Author

A former newspaper reporter, Matt McGowan writes about research in the College of Engineering, Sam M. Walton College of Business, School of Law and other areas. He is the editor of Short Talks From the Hill, a podcast of the University of Arkansas. Reach him at 479-575-4246, or dmcgowa@uark.edu.

University of Arkansas logo

Looking for an expert?

The University of Arkansas Campus Experts website is a searchable database of experts who can talk to the media on current events.

Trending Topics:
Cellphone privacy
Net Neutrality
Immigration politics
Mars

Marlis and Michael Douglas on What DNA Can Tell Us About the Health of Wildlife

More Episodes of Short Talks from the Hill

Short Talks From the Hill logo

The University Relations Science and Research Team

Camilla Shumaker
director of science and research communications
479-575-7422, camillas@uark.edu

Matt McGowan
science and research writer
479-575-4246, dmcgowa@uark.edu

Robert Whitby
science and research writer
479-387-0720, whitby@uark.edu

DeLani Bartlette
feature writer
479-575-5709, dbartl@uark.edu

Connect with Us